Skip to main content

Fortress Biotech, Inc.

FBIOP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001429260

In the last 90 days, Fortress Biotech, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Other share classesFBIO

Holders of 5% or more of FBIOP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fortress Biotech, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Fortress Biotech, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Fortress Biotech, Inc., newest first.

No Schedule 13D or 13G filings on Fortress Biotech, Inc. are on file.

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Fortress Biotech, Inc. shares, newest first.

Form 144 notices for FBIOP
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
May 17, 20241:15 PM ETKlein DovDirector10.0K$17.6KMay 20, 2024Merrill LynchSEC